Su, H., Yang, C., Liang, D
Eliquis (apixaban): 2-day deferral
Focus: STEP 2 involved participants with Type 2 Diabetes, while STEP 3 included individuals with obesity or overweight with comorbidities such as high blood pressure and high cholesterol
Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
This dietary intervention trial received ethical approval from the Quadram Institute Bioscience Human Research Governance Committee (QIB01/2024) and the South East Scotland Research Ethics Committee (24/SS/0047) and is registered at ClinicalTrials.gov (NCT06518343)
That means theres no way to know exactly how much semaglutide or tirzepatide they are dispensing, said Davis